Latest news with #BioPharmaChemIreland
Irish Independent
19-06-2025
- Business
- Irish Independent
Astellas celebrates significant award wins for sustainability efforts
Just last month, Astellas was awarded Sustainable BioPharmaChem Company of the Year at the inaugural BioPharmaChem Impact Awards, in recognition of the company's efforts in implementing sustainable and responsible practices in the biopharmachem industry. The awards were held by BioPharmaChem Ireland (BPCI), the Ibec group that represents the biopharmaceutical and chemical sectors in Ireland. In March, Astellas picked up the Commitment to Sustainability Award at the well-known IDA supported Invest in Ireland Awards. These awards reward excellence in the inward foreign direct investment sector in the Republic of Ireland. Astellas won the award in recognition of the environmental and sustainability stewardship the judges felt was at the heart of Astellas' operations. The awards acknowledged Astellas' significant investment in renewable energy, waste reduction and greener manufacturing practices which contributed to its win on the night. Astellas also enjoyed huge success at the Green Awards in February. With 140 companies submitting 280 entries to compete across 29 categories, Astellas received four awards on the night. These included Green Large Organisation of the Year, Sustainability Team of the Year, the Green Lifesciences Award and the Sustainable Energy Achievement Award. Speaking about the award wins, Louis Collins, Executive Director and Site Lead, Astellas Co. Ltd. said: 'Our strong culture of sustainability has been embedded in everything we do since the early 2000s. We're hugely aware of the role our work plays in patients' lives and the communities we operate in. With that in mind, our sustainability approach incorporates all of our key stakeholders, from patients and our community to our employees, with the understanding that our continued growth and success needs to be achieved as sustainably as possible. Through a range of initiatives and ongoing investment in renewable technologies, Astellas Kerry now meets 74% of its energy needs from renewable sources. Since 2005, we have achieved a 98% reduction in CO₂ emissions and a 70% reduction in the generation of non-hazardous waste. These award wins are a clear demonstration that our operations reflect our commitments to our stakeholders.'
Irish Examiner
07-05-2025
- Business
- Irish Examiner
Ireland ready to be global leader in high-value biopharma services
A new BioPharma Business Services (BBS) strategy will be launched today for Ireland's biopharmaceutical and chemical sector. The strategy aims to position Ireland as a hub for global services by leveraging the country's position as a leading manufacturing location and diversifying and strengthening the industry ecosystem in the country. BioPharmaChem Ireland (BPCI), the Ibec group that represents the sector, launches the strategy at the Impact 2025 conference and awards taking place at the Killashee House Hotel in Naas. Nearly 9,500 professionals, representing close to 20% of total BioPharmaChem employment in Ireland, work in BBS. BBS is one of the fastest growing industry segments, expected to grow by 10% by 2027. "Our new strategy focuses on value stream enhancement, talent development, cutting-edge digital and AI infrastructure, and a vibrant ecosystem, to position Ireland as the global leader in innovative, high-value biopharma services," said Pfizer finance and global business services vice president Aoife Allen, who is the chair of BPCI's BBS steering committee. More than 300 life science professionals are attending the conference in Naas. "It's an important time for the ecosystem to come together to understand the challenges and explore opportunities to support the development of the industry," said BioPharmaChem Ireland director Sinead Keogh. "To ensure competitiveness, it is vital that Ireland prioritises investments in critical areas such as skills and talent, energy and infrastructure, public sector research and innovation, and regulatory simplicity. We welcome the new Government's commitment to a National Life Sciences Strategy and Action Plan on Competitiveness and Productivity. These priorities must remain at the forefront of policy agendas to secure the sector's long-term resilience."
